WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016095839) APPLICATION OF BINDING MOLECULE FOR SPECIFIC BINDING OF PRECURSOR FOR BRAIN-DERIVED NEUROTROPHIC FACTOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/095839    International Application No.:    PCT/CN2015/097820
Publication Date: 23.06.2016 International Filing Date: 18.12.2015
IPC:
A61K 39/395 (2006.01), A61P 37/00 (2006.01)
Applicants: SHANGHAI YILE BIOTECHNOLOGY CO., LTD [CN/CN]; Room 300, 3F, Building 6 No. 333, Guiping Road, Xuhui District Shanghai 200231 (CN)
Inventors: LI, Changqi; (CN).
WANG, Huamao; (CN).
DAI, Ruping; (CN).
CAI, Xiumei; (CN).
ZHOU, Xinfu; (CN)
Agent: SHANGHAI PATENT & TRADEMARK LAW OFFICE, LLC; 435 Guiping Road Shanghai 200233 (CN)
Priority Data:
201410811678.8 19.12.2014 CN
Title (EN) APPLICATION OF BINDING MOLECULE FOR SPECIFIC BINDING OF PRECURSOR FOR BRAIN-DERIVED NEUROTROPHIC FACTOR
(FR) APPLICATION D'UNE MOLÉCULE DE LIAISON COMME PROTÉINE PRÉCURSEUR DU FACTEUR NEUROTROPHIQUE DÉRIVÉ DU CERVEAU À LIAISON SPÉCIFIQUE
(ZH) 特异性结合脑源性神经营养因子前体蛋白的结合分子的应用
Abstract: front page image
(EN)Disclosed is an application of a binding molecule for specific binding of a precursor for brain-derived neurotrophic factor (proBDNF). The binding molecule for proBDNF is particularly a monoclone antibody of proBDNF, and can be used to prevent, mitigate or treat autoimmune diseases.
(FR)L'invention concerne l'application d'une molécule de liaison comme protéine précurseur du facteur neurotrophique dérivé du cerveau (proBDNF) à liaison spécifique, laquelle molécule de liaison est plus particulièrement un anticorps monoclonal du facteur proBDNF destinée à prévenir, soulager ou traiter les maladies auto-immunes.
(ZH)本发明公开了特异性结合脑源性神经营养因子前体蛋白(proBDNF)的结合分子的应用。所述proBDNF的结合分子,特别是proBDNF的单克隆抗体,能够用于预防、缓解或治疗自身免疫性疾病。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)